Olympus Pays Record Anti-Kickback Penalty For Device Case
This article was originally published in The Gray Sheet
Executive Summary
The endoscope-maker resolved a federal investigation into kickbacks with a $600-million-plus payment, as well as a deferred prosecution agreement and a corporate integrity agreement that come with serious commitments to improving compliance.
You may also be interested in...
Shire To Pay Record-Setting Device FCA Settlement
The $350m settlement resolves False Claims Act allegations Shire and its subsidiaries used tactics including lavish meals, free medical equipment, unearned speaker payments and cash to encourage doctors to prescribe the company’s Dermagraft human skin substitute.
House Subcommittee Reaffirms Health-Care Fraud Focus
Representatives from both parties questioned US federal officials and a contractor as to what could be done to more efficiently stop fraud.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.